Stephen Berenson
Managing Partner at Flagship Pioneering
Cambridge, Massachusetts
Overview
Work Experience
Managing Partner
2017 - Current
Capital formation, value growth and realization, strategic partnerships, strategic and operational initiatives
Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.
Member Board of Directors
2024
Inari is a biotechnology company that aims to transform agriculture and its impact on society and the environment.
Raised $609,000,000.00 from Flagship Pioneering, Rokos Capital Management, State of Michigan Retirement System, Hanwha Impact Partners, Rivas Capital, NGS Super and CPP Investments.
Chairman of the Board
2021
Cellarity is a therapeutics company that uses genomic technologies, data science, and AI to develop a new generation of therapies.
Raised $294,000,000.00 from Kyowa Kirin, Flagship Pioneering and Hanwha Impact Partners.
Chairman Of The Board
2019
Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.
Raised $537,800,000.00 from Oaktree Capital Management.
Member Board Of Directors
2017
Member Board Of Directors
2021 - 2024
Repertoire Immune Medicines is a clinical stage biotechnology company.
Raised $257,275,890.00 from Invus, PSP Investments, SoftBank Vision Fund, Flagship Pioneering and Alaska Permanent Fund.
Member Board Of Directors
2017 - 2021
CIBO scales regenerative advanced platform technology that connects growers to incentives and enterprises to growers.
Raised $67,399,997.00 from Flagship Pioneering and Indigo by Telkom Indonesia.
Vice Chairman
2005 - 2017
Senior Banker
Managing Director
1998 - 2005
Co-head of Technology Investment Banking
Managing Director
1992 - 1998
Equity Capital Markets and Derivatives
Vice President
1984 - 1992
Latin America M&A
J.P. Morgan Ventures Energy Corporation provides commodity risk management solutions in both the physical .
Education
SB
1980 - 1982